Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05267509

An Integrated Radio-immunological Approach

Identification of the Immuno Suppressive Characteristics of Glioma Patients by an Integrated Radio-immunological Approach

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
31 (actual)
Sponsor
Istituto Oncologico Veneto IRCCS · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The most aggressive primary brain tumors in adults, glioblastomas, are characterized by a profound local and systemic immune suppression. During tumor progression, the infiltration of inflammatory leukocytes, especially of myeloid origin, endowed with immunosuppressive function is observed. Aim of this study is to evaluate myeloid cell infiltrate and iron metabolism in tumor-associated macrophages by combining a multimodal MRI imaging technique with immunophenotyping of the tumor microenvironment.

Conditions

Timeline

Start date
2022-02-23
Primary completion
2025-06-30
Completion
2026-12-31
First posted
2022-03-04
Last updated
2026-01-23

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT05267509. Inclusion in this directory is not an endorsement.

An Integrated Radio-immunological Approach (NCT05267509) · Clinical Trials Directory